Epidural labor analgesia in a patient receiving fondaparinux

International Journal of Obstetric Anesthesia

Volumn 18, Issue 1, 2009, Pages 94-95

  Tagaloa, Leinani Aiono Le ^a   Carvalho, Brendan ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BICARBONATE; FONDAPARINUX; HEPARIN; LIDOCAINE;

ADULT; ALLERGIC REACTION; ANTICOAGULATION; CASE REPORT; CESAREAN SECTION; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG SAFETY; DRUG WITHDRAWAL; EPIDURAL ANESTHESIA; EPIDURAL CATHETER; FEMALE; HUMAN; KIDNEY CLEARANCE; LABOR INDUCTION; LABOR PAIN; LETTER; MAXIMUM PLASMA CONCENTRATION; OBSTETRIC ANALGESIA; PREGNANCY; SKIN ALLERGY; VENOUS THROMBOEMBOLISM;

ADULT; ANALGESIA, EPIDURAL; ANTICOAGULANTS; CESAREAN SECTION; FEMALE; GUIDELINES AS TOPIC; HUMANS; POLYSACCHARIDES; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 57749191478     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2008.07.007     Document Type: Letter

References (16)

1. Samama M.M., and Gerotziafas G.T. Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux). Thromb Res 109 (2003) 1-11
2. Wijesiriwardana A., Lees D.A., and Lush C. Fondaparinux as anticoagulant in a pregnant woman with heparin allergy. Blood Coagul Fibrinolysis 17 (2006) 147-149
3. Mazzolai L., Hohlfeld P., Spertini F., Hayoz D., Schapira M., and Duchosal M.A. Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. Blood 108 (2006) 1569-1570
4. Dempfle C.E. Minor transplacental passage of fondaparinux in vivo. N Engl J Med 350 (2004) 1914-1915
5. Lagrange F., Brun J.L., Vergnes M.C., et al. Fondaparinux sodium does not cross the placental barrier: study using the in-vitro human dually perfused cotyledon model. Clin Pharmacokinet 41 Suppl 2 (2002) 47-49
6. Bauer K.A., Hawkins D.W., Peters P.C., et al. Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents: the selective factor Xa inhibitors. Cardiovasc Drug Rev 20 (2002) 37-52
7. Klaeffling C., Piechottka G., Daemgen-von Brevern G., et al. Development and clinical evaluation of two chromogenic substrate methods for monitoring fondaparinux sodium. Ther Drug Monit 28 (2006) 375-381
8. Nilsson C.U., and Engstrom M. Monitoring fondaparinux with the Sonoclot. Blood Coagul Fibrinolysis 18 (2007) 619-622
9. Horlocker T.T., Wedel D.J., Benzon H., et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 28 (2003) 172-197
10. Gogarten W. The influence of new antithrombotic drugs on regional anesthesia. Curr Opin Anaesthesiol 19 (2006) 545-550
11. Vandermeulen E. Guidelines on anticoagulants and the use of locoregional anesthesia. Minerva Anestesiol 69 (2003) 407-411
12. Kozek-Langenecker S.A., Fries D., Gutl M., et al. Locoregional anesthesia and coagulation inhibitors. Recommendations of the Task Force on Perioperative Coagulation of the Austrian Society for Anesthesiology and Intensive Care Medicine. Anaesthesist 54 (2005) 476-484
13. van Kleef J W, de Lange J J, van Everingden J J E et al. Neuraxisblokkade en antistolling. Website publication www.anesthesiologie.nl 2004.
14. Llau J.V., De Andres J., Gomar C., Gomez-Luque A., Hidalgo F., and Torres L.M. Anticlotting drugs and regional anaesthetic and analgesic techniques: comparative update of the safety recommendations. Eur J Anaesthesiol 24 (2007) 387-398
15. Llau J.V., de Andres J., Gomar C., et al. Drugs that alter hemostasis and regional anesthetic techniques: safety guidelines. Consensus conference. Rev Esp Anestesiol Reanim 48 (2001) 270-278
16. European Society of Regional Anaesthesia and Pain Therapy (ESRA): Regional anaesthesia and thromboembolism prophylaxis/anticoagulation. http://www.esra-learning.com/